• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Baxter warns of alarm malfunction on some infusion pumps

February 18, 2022 By Sean Whooley

BaxterBaxter (NYSE:BAX) announced today that it has issued an urgent safety communication regarding upstream occlusion alarms for certain infusion pumps.

Deerfield, Illinois–based Baxter warned that incorrect administration set setup and/or the incomplete resolution of upstream occlusion alarms may result in reduced delivery or non-delivery of medication. The problem might occur without the users receiving alerts via pump alarm in some cases. The issue involves all Spectrum V8 and Spectrum IQ infusion pumps.

Baxter received 51 reports of serious injury and three reports of patient death over five years that may have resulted from incorrect administration set setup or incomplete resolution of upstream occlusion alarms.

The information was originally sent to customers in an urgent safety communication notification on Dec. 29, 2021, according to a news release.

Customers informed Baxter that the pump was not delivering medication at the programmed rate displayed on the screen and, in some cases, was not alarming for upstream occlusions. After an upstream occlusion alarm, the occlusion must be fully resolved before restarting the pump. Failure to do so potentially results in the pump not re-alarming as expected, which can interrupt therapy and/or cause under-infusion.

Potential harm varies based on factors including length of therapy delay, medication being infused, volume and rate of infusion and the patient’s underlying status and comorbidities.

Customers may continue to use Spectrum V8 and Spectrum IQ infusion pumps by following on-screen instructions and referencing the operator’s manual-external link disclaimer for infusion setup instructions, according to Baxter. Users must completely spike the IV container, remove the blue slide clamp, disengage the blue slide clamp from the IV tubing, make sure that the IV tubing is clear of kinks or collapsed sections, ensure the roller clamp is released prior to infusion start and ensure that rigid and semirigid containers are properly vented, all in order to help prevent upstream occlusions.

Baxter said that after the infusion begins, users should verify that drips are flowing in the drip chamber. If an upstream occlusion remains after the RUN/STOP key is pressed, the pump may appear to be infusing normally but could be infusing below the programmed rate or not at all. If a clinician suspects infusion was resumed without clearing an occlusion, they should stop the infusion with the RUN/STOP key, clear the occlusion and restart the infusion.

Baxter distributes Spectrum V8 and Spectrum IQ infusion pumps in the U.S., Puerto Rico, Canada and certain Caribbean islands.

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls Tagged With: Baxter

IN CASE YOU MISSED IT

  • Tandem Diabetes Care delivers 1 million insulin boluses using t:connect mobile app
  • Nuvo, Sheba Medical Center develop AI-powered gestational diabetes management platform
  • Verily’s Onduo, Sword Health collaborate on virtual diabetes care
  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS